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Clinics and pathology 
Disease 
Non Hodgkin lymphoma (NHL). 
Phenotype / cell stem origin 
2 cases of diffuse large B-cell lymphoma (DLBL) with 
BCL6/ZNFN1A1 involvement, 1 NHL with BCL6 
involvement, 1 follicular, predominantly large cell B-
NHL and one T-NHL without gene ascertainement. 
Epidemiology 
5 cases to date, aged 40-70 years, sex ration: 3M:1F. 
Prognosis 
The 2 patients with BCL6/ZNFN1A1 involvement died 
at 16 and 17 months after diagnosis. 
Cytogenetics 
Additional anomalies 
del(6) in two cases, del(13q) in two cases, +16 in two
cases, +12 in one case. 




Transcription factor; belongs to the Krüppel family, 







Transcription regulator; can repress transcription 
through the recruitment of histone deacetylase 
complexes; role in conjunction with Aiolos; 
hemopoietic-specific zinc finger protein regulator of B 
and T-cell differentiation. 




5’ Ikaros - 3’ BCL6 fusion transcript; it is supposed 
that substitution of the promoter of BCL6 may be 
responsible for BCL6 deregulation. 
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